日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

DUETTE: a phase II randomized, multicenter study to investigate the efficacy and tolerability of a second maintenance treatment in patients with platinum-sensitive relapsed epithelial ovarian cancer, who have previously received poly(ADP-ribose) polymerase (PARP) inhibitor maintenance treatment

DUETTE：一项 II 期随机、多中心研究，旨在探讨对铂敏感复发性上皮性卵巢癌患者（既往接受过聚（ADP-核糖）聚合酶（PARP）抑制剂维持治疗）进行第二次维持治疗的疗效和耐受性。

期刊:International Journal of Gynecological Cancer
影响因子:4.7
doi:10.1136/ijgc-2020-001694
McMullen, Michelle; Karakasis, Katherine; Loembe, Bienvenu; Dean, Emma; Parr, Graem; Oza, Amit M
PARP
肿瘤
肿瘤免疫
卵巢癌
发表日期：2020
文献求助 收藏

Expanding the phenotype of metabolic cutis laxa with an additional disorder of N-linked protein glycosylation

将代谢性皮肤松弛症的表型扩展为伴有N-连接蛋白糖基化障碍

期刊:European Journal of Human Genetics
影响因子:4.6
doi:10.1038/s41431-017-0044-8
Witters, Peter; Breckpot, Jeroen; Foulquier, François; Preston, Graem; Jaeken, Jaak; Morava, Eva
代谢
发表日期：2018
文献求助 收藏

OCT2, SSX and SAGE1 reveal the phenotypic heterogeneity of spermatocytic seminoma reflecting distinct subpopulations of spermatogonia

OCT2、SSX 和 SAGE1 揭示了精母细胞瘤的表型异质性，反映了精原细胞的不同亚群

期刊:Journal of Pathology
影响因子:5.6
doi:10.1002/path.2919
Jasmine Lim, Anne Goriely, Gareth Dh Turner, Katherine A Ewen, Grete Krag Jacobsen, Niels Graem, Andrew Om Wilkie, Ewa Rajpert-De Meyts
细胞生物学
肿瘤
其它细胞
发表日期：2011
文献求助 收藏

AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies

AZD7762 是一种新型检查点激酶抑制剂，可促进检查点废除并增强 DNA 靶向疗法

期刊:Molecular Cancer Therapeutics
影响因子:5.3
doi:10.1158/1535-7163.MCT-08-0492
Sonya D Zabludoff, Chun Deng, Michael R Grondine, Adam M Sheehy, Susan Ashwell, Benjamin L Caleb, Stephen Green, Heather R Haye, Candice L Horn, James W Janetka, Dongfang Liu, Elizabeth Mouchet, Shannon Ready, Judith L Rosenthal, Christophe Queva, Gary K Schwartz, Karen J Taylor, Archie N Tse, Graem
信号转导
发表日期：2008
文献求助 收藏